Principal Scientist II
AbbVie
North Chicago, Illinois
Jamie T. Wasylenko, MS, Principal Scientist II at AbbVie, is renowned for her expertise in analytical strategy and regulatory intelligence. With over two decades of experience in the pharmaceutical industry, Jamie bridges analytical research and development with other functional areas. Her experience spans diverse modalities, including small molecules, biologics, aesthetics, medical devices, and combination products.
A passionate innovator, Jamie excels in driving cross-functional collaboration, ensuring products are developed with their entire lifecycle in mind. She co-leads AbbVie’s ICH Q14 initiative—transforming insightful strategies into actionable plans that enhance regulatory submissions, ensure quality compliance, and sustain commercial supply.
Jamie advances the pharmaceutical industry by actively participating in STEM outreach programs, mentoring students, and networking through professional organizations. She is eager to share her insights on leveraging Analytical Quality by Design to drive innovation and excellence in product development and beyond. As a speaker, Jamie brings a wealth of knowledge, inspiring others to embrace new opportunities and transform possibilities into reality.
Outside of her professional pursuits, Jamie is pursuing an MBA in Data Analytics, further bolstering her strategic influence in the field. She lives in a northwest suburb of Chicago, with her husband and two children, and enjoys exploring the great outdoors.
Disclosure information not submitted.
Adopting ICH Q14: A Modern Approach to Analytical Procedure Development
Wednesday, July 16, 2025
2:00 PM - 2:25 PM ET